Figure 8

Anti-tumor efficacy of administered nanobots on HCT116 spheroids. (A) The tumor mass is expressed as area over a period of 72 h. Tumor disintegration (*) is indicated by reduction in tumor area of spheroids treated with CNT-DOX-Fe3O4-mAb and CNT-DOX-Fe3O4-Tf. (B) Tumor viability under various treatments are depicted as percent survival, compared to control.